1Goodin DS, Frohman EM, Garmany GP, et al. Disease modi- fying therapies in multiple sclerosis. Report of the therapeu- tics and technology assessment subcommittee of the American academy of neurology and the MS council for Clinical Practice Guidelines[J]. Neurology, 2002, 58(2) : 169-178. 被引量：1
2Doggrell SA. Good results for early treatment of clinically iso- lated syndrome prior to multiple sclerosis with interferon beta- lb and glatiramer group[J]. Expert Opin Pharmacother, 2010,11 (7) : 1225-1230. 被引量：1
3Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis[J]. Neurologist,2007,13(2) : 57-72. 被引量：1
4Frohman EM, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS:Report of the therapeutics and teehnol-ogy Assessment Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurolo gy Society[J]. Neurology, 2003,61(5) :602-611. 被引量：1
5Gronseth GS, Ashman EJ. The usefulness of evoked poten tials in identifying clinically silent lesions in patients with sus- pected multiple sclerosis (an evidence based review): Report of the Quality Standards Subcommittee of the American Acad emy of Neurology[J]. Neurology, 2000,54(9) : 1720-1725. 被引量：1
6Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols [J]. Ann Neurol,1983,13: 227-231. 被引量：1
7McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the internationalpanel on the diagnosis of multiple sclerosis[J]. Ann Neurol,2001,50: 121-127. 被引量：1
8Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revision to the "McDonald crite- ria" [J]. Ann Neurol,2005,58 : 840-846. 被引量：1
9Miller A. Revised diagnostic criteria for multiple sclerosis[J]. Ann Neurol, 2011,69:292-302. 被引量：1
10Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic' s syndrome) [J]. Neurology, 1999,53(5) : 1107-1114. 被引量：1
6Masaki K. Molecular pathology of multiple sclerosis and neuromy elitis optica[J]. Nihon Rinsho, 2014,72 ( 11 ) : 1909. 被引量：1
7Kurosawa K, Fujihara K. Clinical concept, etiology and pathology of neuromyelitis optica[J]. Nihon Rinsho, 2014,72(11) :1897. 被引量：1
8Tanaka K, Tanaka M. Pathogenesis of autoantibodies in demyelin- ating disorders of the central nervous system[J]. Nihon Rinsho, 2014,72(11) :2067. 被引量：1
9EIOH, Dany F, EI MB, et al. Intractable hiccup and vomiting, neuropathic pruritus and tonic spasms in a case of neuromyelitis optica spectrum disorder[J]. Acta Neurol Belg, 2015,79 : 562. 被引量：1
10Qi X,Sun C. Pay attention to the differences and similarities in the pathogenesis and management of multiple sclerosis and neu- romyelitis optica[J]. Zhonghua Yi Xue Za Zhi, 2014, 94(39): 3041. 被引量：1
